Prescience Insilico

Prescience Insilico is a deep tech company that provides AI-driven software, research, and digital transformation services for the pharmaceutical and materials science industries. Its core software platform, PRinS3, integrates artificial intelligence, physics-based modeling, and high-performance computing to support drug discovery processes, including target identification, molecule design, virtual screening, and property prediction. The company also offers research services utilizing multiscale computational chemistry and develops custom digital solutions, such as digital twins, to enhance data management, collaboration, and the integration of machine learning models for materials and life science innovation.

These solutions enable partners to accelerate innovation and optimize research efficiency by addressing complex challenges in drug and materials development. By combining experimental data with advanced machine learning algorithms, the company helps organizations prioritize candidates with improved pharmacokinetic profiles, solubility, and bioavailability. The company’s approach is used to streamline preclinical drug development, improve treatment delivery systems, and support the design of innovative materials, catering to researchers and scientists in life sciences, healthcare, and specialized chemical sectors.